US Patent 12058987 Mouse having a humanized B-cell activating factor gene
Patent 12058987 was granted and assigned to Regeneron Pharmaceuticals on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 15 Aug, 2024
Golden AI
Edits made to:
Infobox (+16 properties)
Article (+361 characters)
US Patent 12058987 Mouse having a humanized B-cell activating factor gene
Article
Patent abstract
Non-human animals, cells, methods and compositions for making and using the same are provided, wherein the non-human animals and cells comprise a humanized B-cell activating factor gene. Non-human animals and cells that express a human or humanized B-cell activating factor protein from an endogenous B-cell activating factor locus are described.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew J. Murphy0
Cagan Gurer0
John McWhirter0
Lynn Macdonald0
Date of Patent
August 13, 2024
0Patent Application Number
172261250
Date Filed
April 9, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12058987 Mouse having a humanized B-cell activating factor gene
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
